Reducing the number of CTs performed to monitor personalized dosimetry during peptide receptor radionuclide therapy (PRRT)

Reducing the number of CTs performed to monitor personalized dosimetry during peptide receptor radionuclide therapy (PRRT)

Abstract Background Peptide receptor radionuclide therapy (PRRT) with [177Lu]-DOTA-TATE is an effective treatment of neuroendocrine tumors (NETs). After each cycle of treatment, patient dosimetry evaluates the radiation dose to the risk organs, kidneys, and bone marrow, the most radiosensitive tissu...

Full description

Bibliographic Details
Main Authors: Alexandre Chicheportiche, Faozi Artoul, Arnon Schwartz, Simona Grozinsky-Glasberg, Amichay Meirovitz, David J. Gross, Jeremy Godefroy
Format: Article
Language:English
Published: SpringerOpen 2018-06-01
Series:EJNMMI Physics
Subjects:
Peptide receptor radionuclide therapy (PRRT)
[177Lu]-DOTA-TATE
Dosimetry
Kidneys
Bone marrow
Single photon emission computed tomography (SPECT)
Online Access:http://link.springer.com/article/10.1186/s40658-018-0211-1

Internet

http://link.springer.com/article/10.1186/s40658-018-0211-1

Similar Items